Axitinib CAS 319460-85-0
Descripción
Axitinib CAS 319460-85-0 Descripción del producto
Product Name: | Axitinib |
Synonyms: | N-Methyl-2-({3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide;Benzamide, N-methyl-2-[[3-[(E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;UNII-C9LVQ0YUXG;;Inlyta;Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;10mg;Axitinib (usan);N-Methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide;AG-013736 N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide;Axtinib;AVERMECTINB;Axitinib;N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide;[14C]-Axitinib |
CAS: | 319460-85-0 |
EINECS: | 638-771-6 |
MF: | C22H18N4OS |
MW: | 386.47 |
Melting Point: | 213-215°C |
Boiling Point: | 668.9±55.0 °C(Predicted) |
Density: | 1.4 |
Appearance: | white to tan Powder |
Purity: | >98% |
Storage: | room temp |
Axitinib CAS 319460-85-0 Fórmula molecular
Axitinib CAS 319460-85-0 Uso
un inhibidor de la tirosina quinasa; utilizado en la terapia del cáncer.
Reviews
There are no reviews yet.